Biomed Briefs

Biomed Briefs

A new partnership to combat screwworm. A look at HIV and TB treatments. How THC reduces side effects of HIV treatment and the first potential measles treatment.

Biomed Briefs

For decades, no one really knew how the drug praziquantel treated schistosomiasis, a parasitic worm infection afflicting more than 200 million people worldwide. Texas Biomed Professor Tim Anderson, PhD, and his team, and researchers at the Medical College of Wisconsin, determined how the drug works on the molecular level to kill the tiny flatworms.

Biomed Briefs

The latest research into a potential Ebola therapy target; reversing prevailing consensus about parasitic worms that infect more than 200 million people worldwide, and a host-directed therapy for patients with TB and HIV.

Biomed Briefs

Research highlights featuring work on Zika and Marburg vaccines, investigating how Ebola virus infects cells and finding where rebound HIV infection originates from.

Biomed Briefs

Research highlights including the next phase of the Strong Heart Study, TB advancements, Zika vaccine, an award-winning children’s game and more.

Biomed Briefs

Research highlights: A promising bladder cancer treatment, diversifying next-gen TB vaccines and using CRISPR to get beyond blood brain barrier for HIV treatment.

COVID-19 Briefs

TEXAS BIOMED AND PARTNERS DISCOVER NEW, POTENT COVID-19 ANTIBODY COCKTAIL Texas Biomed researchers, led by Professor Luis Martinez-Sobrido, PhD, and